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ABSTRACT: Apolipoprotein B (APOB) plays a key role in
lipoprotein metabolism and plasma lipid transport. It has been shown
that about two-thirds of male mice heterozygous for ApoB were
infertile. Moreover, a 3-codon deletion polymorphism (rs11279109)
in the signal peptide region of the APOB gene has been shown to be
a risk factor for infertility in Slovenian men, but its association with
infertility in Indian men has not been evaluated to date. Hence, in the
present study, we have genotyped this polymorphism in 545 Indian
men, including 294 infertile and 251 fertile men. Our results show
that the distribution of this deletion polymorphism was consistent with
the Hardy-Weinberg equilibrium in both infertile and fertile men. No
statistically significant difference was observed in the distribution of
the APOB signal peptide deletion polymorphism between infertile
and fertile men (x2 5 0.156, P5 .925 for genotypes; x2 5 0.015, P5
.903 for alleles). Moreover, no significant difference was observed
when infertile and fertile men were categorized on the basis of
presence (D/D and D/W genotypes) or absence (W/W genotypes) of
deletion (odds ratio, 0.955; 95% confidence interval, 0.644–01.418;
P 5 .820). Our study concludes that the APOB gene deletion
polymorphism is not a risk factor for the development of infertility in
Indian men.
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Approximately 15% of human couples are infertile;about 50% of these cases are due to various factors
or conditions affecting the male. Although we are
familiar with the mechanisms of human reproductive
physiology, the underlying causes of male subfertility
are not fully elucidated (Meschede and Horst, 1997).
Various causative factors include varicocele, obstruction
of spermatic ducts, agglutination of sperm, impotence,
hormonal imbalance, and genetic defect. Y-chromosome
microdeletions in azoospermia factor (AZF) regions
have been found in approximately 10% of infertile
Indian men (Thangaraj et al, 2003a); deletion of DAZ
gene copies and mutation in the autosomal gene DAZL
have also been associated with male infertility (Reynolds
and Cooke, 2005; Yang et al, 2005). Additionally,
mutations in mitochondrial DNA have been associated
with impaired sperm motility (Thangaraj et al, 2003b;
Selvi Rani et al, 2006). However, the underlying genetic
causes of infertility in the large proportion of infertile
men remain largely unknown.
The B apolipoproteins APOB-100 and APOB-48 are
derived from a common structural gene. They play
central roles in lipoprotein metabolism and plasma lipid
transport (Young, 1990; Kim and Young, 1998). APOB-
100 is essential for the assembly of very–low-density
lipoprotein in the liver, whereas APOB-48 is required for
chylomicron formation in the intestine. Knockout
studies on ApoB gene deletion have shown severely
compromised fertility in ApoB heterozygous male mice
(Huang et al, 1995, 1996), whereas another study found
ApoB heterozygous male mice to be fertile (Farese et al,
1995). A 3–amino acid deletion polymorphism in the
signal peptide region has been proven to cause
inefficient translocation of the APOB protein (Sturley
et al, 1994; Benhizia et al, 2001). The presence of the
deletion variant resulted in a 66% reduction in
endoplasmic transport compared with proteins contain-
ing the wild-type signal peptide (Sturley et al, 1994).
Recent studies have associated this deletion polymor-
phism with oligoasthenoteratozoospermia in Slovene
white men (Peterlin et al, 2006). Currently, there is no
available report on the association of this polymorphism
with infertility in Indian men, and studies on mouse
models have yielded a controversial interpretation of the
role of the ApoB gene in spermatogenesis. Our study
evaluated the possibility of association of the APOB
gene deletion polymorphism with infertility in groups of
infertile and fertile Indian men.
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Materials and Methods
Subjects and Controls
Blood samples were collected from men attending the Institute
of Reproductive Medicine (Kolkata, India) and the Infertility
Institute and Research Centre (Hyderabad, India). Informed
written consent was obtained from all participants, and
permission to proceed was granted by the Institute Ethics
Committee. A total of 294 infertile men who did not exhibit
any known medical or genetic cause of infertility, such as
obstruction, injury, endocrinologic defect, or karyotypic
abnormality, were included in the study. Men who exhibited
deletion or mutation in our previous studies on the analysis of
Y-chromosome microdeletions (Thangaraj et al, 2003a; and
Thangaraj et al, unpublished results), DAZ copy deletions
(Rani et al, unpublished results), and mitochondrial ND4 gene
analysis (Selvi Rani et al, 2006) were excluded. A total of 294
infertile men were further identified as 1 of 3 subtypes in
accordance with World Health Organization criteria (World
Health Organization, 2000): 137 azoospermatic (Azoo; no
sperm in ejaculate), 55 oligoasthenozoospermatic (OA; ,206
106/mL sperm concentration and ,50% motile sperm), and
102 oligoasthenoteratozoospermatic (OAT; ,20 6 106/mL
sperm concentration, ,50% motile sperm, and ,30% sperm
with normal morphology). A total of 251 ethnically matched
men who, in accordance with WHO criteria (World Health
Organization, 2000), exhibited normal semen parameters (25
6 106/mL to 130 6 106/mL sperm concentration, .50%
motile sperm, and .30% with normal morphology) and
possessed normal levels of inhibin B, testosterone, leutinizing
hormone, and follicle-stimulating hormone were included in
this study as controls. In addition, every fertile man in the
control group had fathered at least one child. Paternity was
verified using short tandem repeat–based DNA fingerprinting
(AmpFlSTR Identifiler kit; Applied Biosystems, Foster City,
California).
Genotyping of APOB Deletion
To genotype the 3-codon deletion polymorphism (rs11279109)
in the signal peptide region of the APOB gene, we designed
and custom synthesized (Sigma-Proligo; Proligo Singapore Pty
Ltd, Singapore, Singapore) primers as described previously
(Peterlin et al, 2006). The sequences of the primers used were
forward primer 59-FAM-CTCCTCAGCCCCTCCATC-39,
and reverse primer 59-GAGTGCCCTTCTCGGTTG-39,
which amplified polymerase chain reaction (PCR) products
of 366/375 bp. PCR for each sample was performed in 0.2-mL,
thin-walled tubes using 2.0 ng of DNA, 2 to 5 pm of each
primer, 200 mM dinucleotide triphosphates, 106 PCR buffer,
1.5 mM MgCl2, and 0.5 units of AmpliTaq Gold (Applied
Biosystems). Because the guanine cytocine content of the
amplified region is very high (76.8%), 20% (v/v), 5M Betaine
(Sigma-Aldrich, St Louis, Missouri) was added as a PCR
enhancer. The PCR reaction was carried out in a GeneAmp
9700 Thermal Cycler (Applied Biosystems) under the following
conditions: 96uC for 10 minutes, 35 cycles at 96uC for 45
seconds, 66uC for 30 seconds, and 72uC for 1 minute, and a
final extension at 70uC for 7 minutes. Amplified products were
analyzed in an ABI 3700xl DNA Analyzer (Applied Biosys-
tems) using GeneScan. For GeneScan, 0.5 mL of PCR product
was mixed with 0.2 mL of GeneScan-500 LIZ Size Standard
(Applied Biosystems) and 9.3 mL of HiDi Formamide (Ap-
plied Biosystems). Raw data were analyzed using GeneMapper
Software, version 4.0 (Applied Biosystems). To reconfirm the
results, we sequenced approximately 80% samples. Sequencing
samples were reamplified using primers without florescent tags
(FAM), and the sequencing reaction was performed as
described previously (Khattri et al, 2009).
Statistical Analysis
Through statistical analysis, the risk of infertility in relation to
the APOB gene signal peptide deletion polymorphism was
estimated using the Statistics Package for Social Sciences,
version 16 (SPSS Inc, Chicago, Illinois). In a x2 test for
association, odds ratios at their 95% confidence intervals were
calculated, and P , .05 was considered significant. The online
resource facility of the Institute for Human Genetics (Munich,
Germany; http://ihg2.helmholtz-muenchen.de/ihg/snps.html)
was used to test for deviation of the Hardy-Weinberg
equilibrium and evaluation of different models of association.
Results
PCR amplification of deletion polymorphism rs11279109
in the signal peptide region of the APOB gene resulted in
products of 375 bp (wild type [W]) or 366 bp (deletion
[D]), which were confirmed by sequencing (Figure 1a)
and GeneScan (Figure 1b). Analysis of the deletion
polymorphism revealed that 24.3% of fertile and
23.47% of infertile men carried the deletion (D/D and
D/W) genotypes (Table; Figure 2). This deletion poly-
morphism was in Hardy-Weinberg equilibrium in both
infertile and fertile men. The heterozygosity index of this
locus in our population was 0.213. No significant
difference was observed when distribution of genotypes
or alleles was compared between fertile and infertile men
(x25 0.156, P5 .925 for genotypes; x25 0.015, P5 .903
for alleles). Furthermore, no significant difference was
observed when any of the individual patient subgroups
(Azoo, OAT, and OA) was compared either with another
subgroup or with fertile men, or when categorizing fertile
and infertile men (and their subgroups) based on the
presence (D/D and D/W) or absence (W/W) of deletion
(Table). The frequency of individuals carrying the
deletion was, however, increased in azoospermic men.
Discussion
Sperm maturation involves a broad range of processes
that occur during sperm migration through the seminif-
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erous tubules and the epididymis, including the remod-
eling of sperm membrane components (De Vriese and
Christophe, 2003). The plasma membrane of sperm
plays a very active role in its fertilization capacity and in
spermatozoon-oocyte cross-talk. Its biochemical consti-
tution is one of the main fields of interest in the study of
sperm physiology and pathology (Lenzi et al, 1996).
Because APOB is one of the apolipoproteins that play
an important role in lipoprotein metabolism, there is a
potential role for APOB in male infertility, because this
polymorphism alters the structure of the signal peptide
of the gene central to lipid metabolism (Visvikis et al,
1990). Moreover, some other genes affecting lipid
metabolism have been associated with infertility in
knockout mice, such as the apolipoprotein E receptor-
2 (Apoer2; Andersen et al, 2003), acid sphingomyelase
(Asm; Butler et al, 2002), and adenosine triphosphate–
binding cassette transporter 1 (Abca1; Selva et al, 2004)
genes. A prior study (Peterlin et al, 2006) has found
significantly increased proportions of D/D and D/W
genotypes among OAT men in the Slovene white
population, but we did not find any significant
difference in the deletion frequency (D/D and D/W
genotypes) between fertile and infertile men or sub-
groups of infertile men (Azoo, OA, and OAT). Rather,
the frequency of deletion was slightly decreased in OAT
(20.59%) and OA (20.20%) men (Table). Although the
authors of the Slovenian study reported the association
of deletion within OAT, it was marginally significant (P
5 .014; at 95% significance level, when Bonferroni
correction applied: P , .05/2 5 .025). The difference
between these 2 studies could very well be explained by
the ethnic difference of the study populations. The most
notable difference is the frequency with which D/D and
D/W deletion genotypes occur: 52.8% of fertile men
carried a deletion in the population studied by Peterlin
et al (2006), whereas only 24.4% carried a deletion in our
study. This difference was not surprising to us, knowing
the unique ethnic origin of Indian populations. Earlier,
we contrasted the results of the studies performed on
Indian populations compared with other populations;
for example, CAG repeat expansion in the androgen
receptor was reported to be associated with male
infertility (Patrizio et al, 2001), but our study did not
find an association (Thangaraj et al, 2002). Similarly,
the A386G polymorphism in the DAZL gene was not
associated with male infertility in Indian males (Than-
garaj et al, 2006), but it was found to be associated with
severe spermatogenic failure in the Taiwanese popula-
Figure 1. Alleles of APOB gene signal peptide deletion polymorphism.
(a) Sequences of individuals with wild-type (W) and deletion (D)
alleles. (b) GeneScan results of individuals with W/W, D/W, and D/D
genotypes. Color figure available online at www.andrologyjournal.org.
Table. Association of APOB gene signal peptide deletion polymorphism with infertility considering deletion (D/D and D/W) as a
risk factor
Genotype
Study Group
Fertile Men Infertile Men Azoospermia OAT OA
W/W 190 (75.70) 225 (76.53) 100 (72.99) 81 (79.41) 44 (80.00)
D/D and D/W 61 (24.30) 69 (23.47) 37 (27.01) 21 (20.59) 11 (20.20)
Odds ratio . . . 0.955 1.152 0.808 0.779
95% confidence
interval . . . 0.644–1.418 0.717–1.853 0.461–1.414 0.379–1.601
P . . . .82 .559 .45 .489
Abbreviations: . . . , not applicable; D, deletion; OA, oligoasthenozoospermia; OAT, oligoasthenoteratozoospemia; W, wild type.
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tion (Teng et al, 2002). Similar patterns were observed in
other genes involved in sex determination (Rajender et
al, 2006), alcoholism (Bhaskar et al, 2007; Rao et al,
2007), mitochondrial disorders (Vanniarajan et al,
2006), and cardiomyopathies (Dhandapany et al, 2009).
This is the first study on Indian men and second study
worldwide addressing the association of the APOB gene
signal peptide deletion polymorphism with male infer-
tility. Men with 1 of 3 different phenotypes of infertility
(Azoo, OA, and OAT) were included in our study, but
no association with the APOB signal peptide deletion
polymorphism was detected in any of them. Our results
suggest that the polymorphism is not associated with
infertility in Indian men, although it has been shown to
be associated with OAT in Slovene white men (Peterlin
et al, 2006). Knockout mouse studies on the APOB gene
also produced confusing results: two-thirds of male
ApoB heterozygous mice were found infertile, despite
normal genitourinary system function and mating
behavior (Huang et al, 1995). Sperm from these
heterozygous knockout males failed to fertilize eggs,
either in vivo or in vitro. These sperm were able to
fertilize eggs once the zona pellucida was removed, but
they displayed persistent abnormal binding to the egg
after fertilization. In vitro fertilization–related and other
experiments revealed that reduced sperm count, motil-
ity, and survival time also contributed to the infertility
phenotype. Furthermore, when the genomic sequence
encoding human APOB was introduced into genetically
engineered animals, normal fertility was restored
(Huang et al, 1996). Contrary to the above studies,
infertility was not reported in the study by Farese et al
(1995) on APOB heterozygous male mice. Peterlin et al
(2006) and our study have produced contrasting findings
on the APOB gene signal peptide deletion polymor-
phism. Accordingly, we expect similar trends in other
populations. Therefore, it is important to perform
replicate studies on patients from diverse ethnic origins
before either designating or excluding this polymor-
phism as a risk for male infertility.
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